Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
DJD vs SCHD: Weighing Concentrated Yield Against Diversified Quality

DJD vs SCHD: Weighing Concentrated Yield Against Diversified Quality

Key Takeaways

  • Different construction: DJD is a yield-weighted fund of roughly 30 Dow Jones Industrial Average members, while SCHD tracks a quality-screened index of about 100 dividend-paying U.S. stocks.
  • Concentration gap: DJD's top 10 holdings represent roughly 57–60% of assets versus about 40–42% for SCHD, giving DJD materially higher single-stock risk.
  • Cost comparison: Both are low-cost, but SCHD's 0.06% expense ratio slightly undercuts DJD's 0.07%.
  • Sector tilt: DJD is heavily weighted to healthcare, while SCHD spreads exposure more evenly across consumer staples, healthcare, technology, and energy.
  • Scale and liquidity: SCHD holds well over $100 billion in AUM (assets under management), making it far larger and more liquid than DJD.
  • Tickeron AI Verdict: SCHD is the ticker of choice for its superior diversification, quality screening, and cost efficiency.

Why This Comparison Matters Now

Dividend-focused ETFs have drawn renewed attention as investors search for income and lower-volatility equity exposure amid shifting interest-rate expectations. DJD and SCHD are two of the most recognizable names in this space, yet they pursue that goal through very different structures. DJD isolates high-yielding names from the 30-stock Dow Jones Industrial Average, while SCHD applies a disciplined quality screen across a much broader universe of roughly 100 dividend payers. This ETF comparison matters because the two funds are not direct substitutes: one offers concentrated yield, the other offers diversified dividend quality. Understanding their relative positioning helps investors align a fund with their own income and risk objectives.

Understanding DJD

DJD is a passively managed smart-beta fund that tracks the Dow Jones Industrial Average Yield Weighted Index. Rather than replicating the price-weighted Dow, it reweights the index's dividend-paying constituents according to trailing 12-month dividend yield, tilting the portfolio toward the highest-yielding mega-cap names. The fund holds roughly 30 positions and is classified as non-diversified, meaning a handful of issuers can dominate returns.

Top holdings have recently included VZ, MRK, CVX, AMGN, JNJ, IBM, KO, CSCO, UNH, and PG. Sector exposure leans heavily on healthcare, followed by financials, technology, and consumer staples. The expense ratio is 0.07%, and the fund's three-year beta of roughly 0.7 indicates lower sensitivity to broad-market swings than the typical large-cap blend fund. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Understanding SCHD

SCHD is a passively managed fund that tracks the Dow Jones U.S. Dividend 100 Index. Its methodology screens for companies with a record of consecutive annual dividend payments, then ranks them by fundamental quality metrics including cash flow relative to total debt, return on equity (ROE, a measure of profitability), dividend yield, and five-year dividend growth. The result is a portfolio of about 100 holdings weighted by market capitalization.

Recent top holdings have included QCOM, TXN, PG, KO, MRK, CVX, ABT, COP, HD, and UNH. Sector weightings are comparatively balanced across consumer staples, healthcare, technology, and energy. The expense ratio is 0.06%, and the fund's beta of roughly 0.7 reflects its defensive, value-oriented character.

The Broader Market Context

Both funds sit at the intersection of two powerful themes: the persistent investor appetite for yield and a rotation toward value and quality in a higher-for-longer rate environment. Dividend strategies have benefited from steady corporate earnings and record free cash flow among large-cap payers, while energy and healthcare names have provided income and defensive ballast. Regulatory scrutiny of healthcare pricing and volatile commodity prices remain key sector risks. Meanwhile, the income segment has drawn substantial capital flows as investors seek alternatives to cash yields and bonds, supporting the structural appeal of dividend ETFs across recent market cycles.

How Performance and Positioning Compare

Over recent months, both ETFs have participated in the broader value and dividend rally, though their drivers differ. DJD's concentrated yield weighting means its returns are more sensitive to the performance of a handful of high-yielding healthcare and communication names, which can amplify both upside and downside. SCHD's broader, quality-filtered portfolio has historically displayed steadier relative positioning, with less reliance on any single issuer or sector. In periods when mega-cap dividend payers lag, DJD's concentration can create a wider performance gap; when those names lead, the yield tilt can outperform. SCHD's lower top-10 concentration and deeper liquidity generally translate into a smoother volatility profile over full market cycles.

Refining My ETF Analysis with AI Tools

When evaluating dividend strategies like these, I often rely on Tickeron's AI Screener to quickly compare holdings, sector exposures, and risk metrics across similar funds. It allows me to filter by fundamentals, volatility, and AI-driven signals, which helps surface how SCHD stacks up against more concentrated options in real time. This approach keeps the research process efficient without replacing my own judgment on allocation decisions.

Tickeron AI Verdict

Based on structural strength, cost efficiency, diversification profile, and trend consistency, Tickeron's AI would likely favor SCHD over DJD at present. SCHD's roughly 100-stock portfolio offers meaningfully better diversification, a more disciplined quality screen, a marginally lower expense ratio, and substantially greater liquidity and scale. While DJD's yield weighting can deliver higher income and stronger short-term outperformance when high-yielding mega-caps lead, its concentration introduces greater single-stock and sector-specific risk. On a risk-adjusted, probabilistic basis, SCHD's broader exposure and steadier relative positioning give it the more durable profile for most dividend-focused investors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD, DJD

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


SCHD in upward trend: price rose above 50-day moving average on October 15, 2026

SCHD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 44 of 50 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on SCHD as a result. In 71 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.

The Moving Average Convergence Divergence (MACD) for SCHD just turned positive on October 09, 2026. Looking at past instances where SCHD's MACD turned positive, the stock continued to rise in 39 of 46 cases over the following month. The odds of a continued upward trend are 85%.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.

Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 266 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 282 of 364 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 35 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

SCHD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), Verizon Communications (NYSE:VZ).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 59.37B. The market cap for tickers in the group ranges from 379.8M to 441.89B. CVX holds the highest valuation in this group at 441.89B. The lowest valued company is AMSF at 379.8M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 1%. For the same ETF, the average monthly price growth was 9%, and the average quarterly price growth was 15%. WEN experienced the highest price growth at 18%, while AMSF experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 1%. For the same stocks of the ETF, the average monthly volume growth was 4% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 41
Price Growth Rating: 40
SMR Rating: 42
Profit Risk Rating: 57
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeValue

Category
Large Value
Address
Schwab Strategic Trust101 Montgomery StreetSan Francisco
Phone
1-800-435-4000
Web
www.csimfunds.com.
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
META shares are tumbling approximately 8.61% in premarket trading on April 30, 2026, falling from a prior session close of $669.12 to around $611.54. The primary catalyst is a sharply raised 2026 capital expenditure forecast of $125 billion–$145 billion, up from a prior range of $115 billion–$135 billion, signaling a major acceleration in AI infrastructure spending that will weigh on free cash flow.
KLAC shares are declining approximately 6.40% in premarket trading on April 30, 2026, retreating from a prior session close of $1,816.21 to roughly $1,700.00. The primary catalyst is a classic "beat and retreat" earnings reaction — Q3 fiscal 2026 results exceeded estimates on both revenue and EPS, yet investor expectations heading into the print were elevated following a sharp pre-earnings rally.
DJD vs SCHD: Weighing Concentrated Yield Against Diversified Quality